MedTrace Logo

Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging

NCT02983838 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-12-06

No results posted yet for this study

Summary

Target of the research Based on change of Brain-derived neurotrophic factor and other pro-inflammatory cytokine along with symptom improvement following treatment, the investigators are trying to find the new treatment target molecule. The investigators will follow up the subjective and objective cognitive dysfunction with psychiatric symptom profiles and compare the neuroimaging related to these change.

Conditions

Sponsors & Collaborators

  • Sungkyunkwan University

    collaborator OTHER

  • Korea University

    collaborator OTHER

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Hong Jin Jeon, M.D.,Ph.D. · Samsung Medical Center, Sungkyunkwan University

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02983838 on ClinicalTrials.gov